Facial Fillers:
ArteFill
|
Captique
|
Cosmoderm - Cosmoplast
|
Evolence
|
Hylaform
|
Juvederm
|
Perlane
|
Radiance
|
Radiesse
|
Restylane
|
Sculptra
|
ArteFill - The first truly permanent injectable filler
FDA approved for
|  |
Artes Medical, the Company that made and distributed ArteFill is no longer in business... some physicians may still have this product in stock but it is becoming rarer to find. Investigate other Facial Fillers
ArteFill® is a unique combination of homogeneous precision-filtered microspheres suspended in a solution of purified collagen gel and 0.3% lidocaine to alleviate discomfort during injection. ArteFill is designed to correct facial wrinkles, the creases around the mouth known as the nasolabial folds. ArteFill is comprised of a combination of precision-filtered microspheres and purified bovine collagen. All of the microspheres have a defined size of 30 to 50 microns in diameter and have a smooth, round surface. The microspheres make up 20% of the formula and the collagen is the other 80%. Aesthetic results are visible immediately after injection. The microspheres cannot be attacked by scavenger cells (macrophages) or degraded by enzymes. Thus, the microspheres will remain intact beneath the creases, providing a permanent support structure to support the wrinkle and to prevent further wrinkling. As with all products using bovine collagen, a skin sensitivity test must be performed prior to use.
Los Angeles, CA (PRWEB) November 17, 2006 --
The approval of ArteFill, a new category of aesthetic injectable products for men and women, was announced today by the United States Food and Drug Administration. ArteFill is the first and only non-resorbable aesthetic injectable implant approved by the FDA. Unlike existing dermal fillers that are completely metabolized by the body, ArteFill is the first non-resorbable dermal filler providing a permanent support structure for enduring wrinkle correction. Douglas Hamilton M.D. has used ArteFill in FDA clinical trials, at his Beverly Hills & Woodland Hills, California offices, to treat deep wrinkles, depressions under the eyes and depressed acne scars. Composed of PMMA (Polymethylmethacrylate), lidocaine, and bovine collagen, Artefill can eliminate unsightly lines and wrinkles, leaving the skin looking younger, radiant, and revitalized for many years. Effects look extremely natural. There is immediate improvement as the area treated is raised to about normal skin level. Generally, there is virtually no discomfort at all at the time of the treatment, since it is mixed with an anesthetic. The procedure is typically done in 2 stages spaced 3 months apart. Dr. Douglas Hamilton treated the first patient in the United States and has the largest series of treated patients in the nation. In 2000, Dr. Hamilton also published the first report in a medical journal, Cosmetic Dermatology, about the treatment of patients with this filler. He gave the first major addresses in 1999 & 2000 to the American Academy of Dermatology in New Orleans & San Francisco at national meetings. These meetings are the largest meetings of dermatologists in the world. Dr. Hamilton is an Assistant Clinical Professor of Dermatology at UCLA School of Medicine.
|
|
Cosmetic & Plastic Surgery
Other Cosmetic Procedures
|
Related Stories about ArteFill:
Injectables: An Uncomplicated Solution for Aging Skin - Injectables are becoming one of the most frequently used solutions for maintaining a youthful, rested appearance. Their ease-of-use and effectiveness no doubt contribute to their popularity. Artes Medical, Inc. - Announces Completion of Artefill Skin Test Study - Artes Medical Announces Completion of Enrollment and Treatment in ArteFill Skin Test Study Artes Medical Announces Winner of ArteFill Face Forward Makeover Contest - Ohio Woman Undergoes Transformation Into Runway-Worthy Modern Mom Artes Medical Initiates Market Launch and Commercial Sale of Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler - "The Feel Good Filler" Delivers Comfort, Affordability, and Immediate Results Artes Medical Reports Growing Demand for ArteFill with More Than Ten Thousand Patients Treated - ArteFill, the first and only FDA-approved non-resorbable injectable dermal filler, provides patients and doctors with a long-lasting solution for the correction of nasolabial folds, or "smile line" wrinkles. Move Over, Popular Beauty Fillers--Here Comes Evolence® - SKINTASTIC™ is pleased to announce the arrival of newly FDA-approved Evolence®--the latest injectable collagen filler in the Skintastic arsenal of little- or no-downtime beauty treatments. EVOLENCE® utilizes highly-purified porcine Type I collagen, regarded as a preferred medical grafting substance due to its nearly identical similarity to human collagen. Artes Medical Broadens Product Portfolio Through Exclusive U.S. Sales and Marketing Agreement for Elevess, a New FDA-Approved Hyaluronic Acid-Based Dermal Filler - Through this agreement, Artes Medical’s dedicated sales force will market and sell Elevess, the first FDA-approved HA dermal filler for the temporary correction of facial wrinkles that is formulated with an anesthetic for patient comfort, as well as the company’s flagship product, ArteFill, the first and only FDA-approved non-resorbable wrinkle filler for long-lasting correction of smile line wrinkles Artes Medical Launches “The ArteFill Face Forward Makeover Contest: Celebrating Women’s Changing Lives” - Artes Medical, Inc. (Nasdaq:ARTE), maker of the long-lasting dermal filler ArteFill®, is celebrating women’s changing lives with the ArteFill Face Forward Makeover Contest. Women age 35 and over are invited to submit personal stories about a current or upcoming time of personal change. Four winners, selected by a panel of judges, will be honored with makeovers worth approximately $10,000 Non-Surgical Nose Job Shown on Fox Channel 10 in Phoenix - Using the permanent facial filler ArteFill, a doctor performs a live demonstration on the tv news of a non-surgical nose shaping procedure. Dermatologic Surgery Journal Publishes Comparison of Global PMMA-Based Dermal Fillers Showing Superior Characteristics of ArteFill Microspheres - This newly published study evaluated five different PMMA products available over the past several years in the U.S. (one product), Europe (one product), Brazil (two products) and Canada (one product) for PMMA microsphere size and morphology using Scanning Electron Microscope (SEM) techniques. Each of the five products was evaluated with respect to PMMA microsphere size, homogeneity and surface characteristics. Results from the comparison show marked differences with respect to PMMA microsphere size and morphology. Products obtained from various markets outside the U.S. over time contained variable PMMA particle sizes with shape and surface irregularities, whereas the U.S. product, ArteFill, demonstrated round, smooth, uniformly sized particles. Chicago Podiatrist Initiates Clinical Study to Evaluate ArteFill for Podiatric Disorder - The clinical study investigator, Mary Olszewski, DPM, American Board of Podiatric Orthopedic & Primary Podiatric Medicine, reports that she is conducting this study to evaluate ArteFill for the reduction of pain and impact on activity level caused by fat pad loss in the plantar metatarsal area in patients who have pain in their feet and who have failed the use of traditional conservative therapies such as pads, shoe wear, orthotics and /or possible use of other temporary injectable dermal filler materials. Douglas Abel Joins Artes Medical’s Board of Directors - Mr. Abel previously served as Vice President of the Dermatology Business Unit of Biogen Idec, Inc. He also formerly served as Director of Marketing, Botox®, at Allergan, Inc. and prior to that, as a Senior Product Manager in Allergan’s skin care division.
ArteFill discussed on Sacramento & Company - ArteFill, the only FDA approved permanent cosmetic facial filler, is discussed on Sacramento & Company in the Sacramento, Stockton, Modesto area. ArteFill May Fill Wrinkles - Forever - A new wrinkle filler that made quite a buzz when it hit the Bay Area is really taking off. Artes Medical Reports Strong Consumer Interest, Rapid Patient Enrollment and Positive Feedback in Largest U.S. Dermal Filler Clinical Study - Feedback from both physicians and patients to date has been very positive, with high levels of interest from consumers to participate in the study. The Nation’s Leading Plastic Surgeons Learn about ArteFill’s Five Year Safety and Long-Term Efficacy Data - In addition to presentations on ArteFill’s safety, long-term efficacy, and differences among various dermal filler products, leading plastic surgeons had the opportunity to observe ArteFill in action. Dr. Cohen provided a live patient demonstration with ArteFill injections during “The Importance of Non-Surgical Options in Your Practice” session, showcasing ArteFill’s ease of injection, immediate correction and minimal downtime. Clinical Data Demonstrates 5-Year Efficacy and Safety of Aquamid(R) in Facial Augmentation - 5-year European Clinical Study shows more than 90% Patient and Physician Satisfaction Artes Medical Reports Over Seven Thousand Patients Treated with ArteFill since February 2007 Product Launch - Artes Medical reported that dermatologists, plastic surgeons and cosmetic surgeons are actively integrating ArteFill into their practices and estimates that over 7,000 patients have been treated with the enduring solution, ArteFill, since the product launch in February 2007. ArteFill.com Website Launched to Consumers - Artes Medical, Inc. (Nasdaq:ARTE) a medical technology company whose product ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of “smile line” wrinkles, today reported the launch of its new consumer-oriented website, ArteFill.com. Long Lasting Injectable Fillers Can Replace Traditional Facial Surgery for Some Patients - Los Angeles Doctor uses Artefill, a FDA approved permanent filler, for non-surgical nose jobs, check and chin augmentations Artes Medical's 5-Year Safety and Efficacy Data Presented at the American Academy of Dermatology Conference - Mark G. Rubin, MD from the University of California in San Diego presented data from a 5-year study on the product ArteFill during the American Academy of Dermatology 66th Annual Meeting Artes Medical Wins Most Innovative New Product At Connect Awards in San Diego - SAN DIEGO's CONNECT announced the winners of the 2007 Most Innovative New Product (MIP) Awards. Mayor Jerry Sanders opened the Awards presentation, which honor the vision, hard work and perseverance that transform ideas and technologies into products. Artes Medical received the award in the Life Sciences - Medical Products category for ArteFill, the first FDA approved permanent injectable filler for wrinkle correction. Artes Medical Names Dr. John F. Kay as Vice President, Engineering and Development - ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of nasolabial fold or "smile line" wrinkles Artes Medical's ArteFill Wins San Diego's CONNECT -Most Innovative New Product- Award - ArteFill is the first and only FDA-approved non-resorbable injectable dermal filler for the correction of wrinkles known as smile lines or nasolabial folds ArteFill name finalist for Connect's MIP award - The San Diego Source reported that Artes Medical's ArteFill Product has been selected as one of the three finalists in the Medical Products category of the 2007 CONNECT Most Innovative New Products "MIP" Awards. Dermatologic Surgery Journal Publishes Landmark Study Showing Positive Five-Year Effects of ArteFill for Smile Lines - Results from the study, led by Steven R. Cohen, MD, Clinical Professor, Division of Plastic Surgery, University of California, San Diego School of Medicine, showcase the safety and aesthetic outcomes over a five-year period in patients treated with ArteFill for nasolabial fold wrinkles. Artes Medical's 5-Year Safety and Efficacy Data Presented at the American Society of Plastic Surgeons (ASPS) Conference - ArteFill(R) live injection demonstration at plastic surgery conference (ASPS) Dr. Stacy Smith Launches Study to Test Duration, Safety and Patient Preference for Dermal Fillers for the Treatment of Smile Lines - Study Compares ArteFill, Radiesse and Restylane Leading Beverly Hills Facial Plastic Surgeon Launches Study to Evaluate ArteFill for ''Non-Surgical Nose Jobs'' - Artes Medical Announces Participation in Prestigious Plastic Surgery and Dermatology Medical Symposia Regarding ArteFill - SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE - News), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced its participation at the following prestigious medical conferences targeted to dermatologists and plastic surgeons in October 2007. Artes Medical Presents at the 34th Annual Scientific Meeting of the American Society for Dermatologic Surgery (ASDS) - SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq:ARTE - News), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced its participation at the recent 34th Annual Scientific Meeting of the American Society for Dermatologic Surgery (ASDS) on October 11-14 at the Sheraton Chicago Hotel & Towers in Chicago, IL. Artes Medical Announces Landmark Five Year Study Results for ArteFill, a Non-Resorbable Dermal Filler - SAN DIEGO--(BUSINESS WIRE)--Artes Medical, Inc. (Nasdaq: ARTE - News), a medical technology company focused on developing, manufacturing and commercializing a new category of aesthetic injectable products for men and women, today announced 5-year safety and efficacy data for ArteFill®, the Company's non-resorbable FDA-approved injectable dermal filler. Experience Enduring Beauty With The Permanent Wrinkle Solution - Plano, Texas (PRWEB) November 1, 2006 -- Dr. Jeffrey Adelglass, M.D., F.A.C.S. of SKINTASTIC in Plano will soon be among the first physicians in Texas to offer a new, unique, and permanent solution to filler re-absorption: ArteFill® from Artes Medical. Long-awaited ArteFill® is finally FDA-approved in the U.S., for the correction of nasolabial folds, or smile lines. Artefill® is the first and only non-resorbable aesthetic injectable implant of its kind approved for use in the U.S.
|
©2002-2009 American Health And Beauty, LLC
Contact Us | Terms of Use |
